Introduction
============

Differences in facial morphology between males and females are well documented, with major shape differences apparent in the jaw, lips, eyes, nose and cheek regions ([@B49]; [@B30]; [@B10]; [@B31]). Although facial sexual dimorphism has now been described in children ([@B28]; [@B37], [@B38]), differences become much more pronounced after the onset of puberty. This accelerated dimorphism post-puberty is the result of changes in circulating hormone levels, which regulate the development and differentiation of male and female primary and secondary sex characteristics, such as voice, body shape and facial morphology ([@B22]). In fact, testosterone levels are 20--30 times higher in males than in females during this developmental stage ([@B15]).

Several studies showed a relationship between testosterone levels (either measured directly or through proxy) and facial morphology, using several different study set-ups and approaches. For example, the second to fourth digit ratio (2D:4D), which is a marker of prenatal androgen exposure, corresponds to measures of facial masculinity and sexually dimorphic facial features ([@B47]; [@B39]). Similarly, [@B54] investigated the effect of prenatal testosterone exposure (measured in umbilical cord blood) on postnatal facial morphology, and showed that higher cord testosterone levels were associated with masculinized facial features. [@B23] showed that facial width/lower facial height decreases, cheekbone prominence decreases, and lower face height/full face height increases under the influence of pubertal testosterone. In a study by [@B36], facial appearance was rated to be more masculine in males with a higher level of bioavailable testosterone. Other evidence for the influence of testosterone on facial morphology comes from the craniofacial differences in boys with delayed puberty before and after testosterone treatment. [@B51] described an accelerated craniofacial growth after testosterone treatment, especially in total mandibular length, ramus length, and upper and anterior facial height.

The amount of circulating testosterone present in the body is the result of many factors, including genetics. Genome-wide association studies (GWAS) have identified multiple variants that influence testosterone regulation in healthy adults ([@B40]; [@B55]; [@B11]; [@B27]; [@B42]; [@B7]; [@B46]), including variants in SHBG, the gene encoding sex-hormone binding globulin. We hypothesize that these variants may also be associated with aspects of facial morphology, particularly those features that demonstrate strong evidence of sexual dimorphism in humans. In this study, we investigated the effect of previously identified genetic variants involved in testosterone regulation on normal-range human facial shape in 7418 European individuals belonging to three cohorts with available 3D facial and genomic data. Additionally, the association between these candidate SNPs and five facial ratios was investigated in a subset of individuals; these ratios have been shown in the literature to correlate with testosterone levels or testosterone-related traits (e.g., aggressive behavior). As a consequence, this study has the potential to shed new light on the biological basis of human facial sexual dimorphism and, more generally, normal-range facial shape variation.

Materials and Methods {#s1}
=====================

Study Sample
------------

The study sample consists of 7418 individuals belonging to three separate cohorts: the Pittsburgh 3D Facial Norms (3DFN) cohort ([@B53]), the Penn State cohort and the Avon Longitudinal Study of Parents and their Children (ALSPAC) cohort ([@B5]; [@B17]). The Pittsburgh 3DFN cohort consists of 2297 participants (age 3--40 years) of self-reported Western-European descent without a history of facial defects or craniofacial surgery. These individuals were recruited at four United States sites: Pittsburgh, PA; Seattle, WA; Houston, TX and Iowa City, IA. The Penn State cohort consists of 1555 subjects (age 18--83 years) of European descent without a history of facial defects or craniofacial surgery, recruited from a number of United States and international sites: State College, PA; New York, NY; Urbana-Champaign, IL; Twinsburg, OH; Dublin, Ireland; Rome, Italy; Warsaw, Poland and Porto, Portugal. 3566 subjects of the Avon Longitudinal Study of Parents and their Children (ALSPAC) cohort (age 14--17 years) were included in this study These subjects are of Western--European descent without a history of facial defects or craniofacial surgery, recruited in Avon, England. ALSPAC recruited 14541 pregnant women resident in Avon, United Kingdom with expected dates of delivery 1st April 1991 to 31st December 1992. 14541 is the initial number of pregnancies for which the mother enrolled in the ALSPAC study and had either returned at least one questionnaire or attended a "children in focus" clinic by 19/07/1997. Of these initial pregnancies, there was a total of 14676 fetuses, resulting in 14062 live births and 13988 children who were alive at 1 year of age. Please note that the study website contains details of all the data that is available through a fully searchable data dictionary^[1](#fn01){ref-type="fn"}^. Genome-wide data was available for 8,952 subjects of the B2261 study which is titled "Exploring distinctive facial features and their association with known candidate genes."

Defining Facial Phenotypes
--------------------------

3D facial surface images were acquired using multiple stereophotogrammetry systems: the VECTRA H1 camera (Canfield Scientific, Parsippany, NJ, United States) and the 3dMDface system (3dMD, Atlanta, GA, United States) were used for the Pittsburgh 3DFN and Penn State cohorts, and the Konica Minolta Vivid 900 laser scanner (Konica Minolta Sensing Europe, Milton Keynes, United Kingdom) was used for the ALSPAC cohort. The process of registration, quality control and segmentation is described in detail in [@B8]. Briefly, the 3D images were imported in Matlab™ 2016b for a spatial-dense registration of the images ([@B9]), in which a symmetrical anthropometric mask was mapped onto the images, leading to a homologous spatial-dense configuration of quasi-landmarks. Subsequently, a two-step image quality control was performed: first, outlier faces were identified by calculating the z-scores from the Mahalanobis distance between the mean face and each subject, and subjects with z-scores higher than two were manually checked; second, a score was calculated that reflects the missing data in the images (due to mesh artifacts or holes) and images with a high score were also manually checked and removed from the dataset when necessary. The spatial-dense configurations then underwent a generalized Procrustes superimposition to eliminate differences in orientation, position and scale ([@B45]). Analyses were done using symmetrized images, created by averaging the original and reflected images (created by changing the sign of the x-coordinate of the original mapped images).

The images were adjusted for the effects of age, age^[2](#fn02){ref-type="fn"}^, sex, weight, height, facial size and the first four principal components (PCs) of genetic ancestry using partial least-squares regression. The images were adjusted in each dataset separately. After the adjustment, segmentation was performed on all three datasets combined to develop multivariate facial phenotypes representing specific facial modules. Briefly, facial modules were defined by grouping vertices that are strongly correlated and connected using hierarchical spectral clustering. The strength of co-variation between the modules was defined using Escoufier's RV coefficient ([@B44]), which is a scalar measure of the strength of association between two groups of variables and is used in morphometric studies on biological shapes ([@B29]). The RV coefficient allowed us to build a structural similarity matrix that defined the hierarchical construction of 63 facial modules, which is represented in Figure [1](#F1){ref-type="fig"}. Subsequently, for each of the 63 modules, quasi-landmarks were aligned via generalized Procrustes superimposition, followed by principal component analysis (PCA) to reduce the dimensionality of the data, and finally parallel analysis to determine the number of PCs needed to adequately capture the shape variation ([@B21]). These linear combinations of PCs formed the multivariate shape phenotypes to be used in genetic association testing (described below).

![Rosette diagram showing the hierarchical global-to-local facial segmentation scheme. A total of 63 facial modules are represented. Modules are indicated in turquoise.](fgene-09-00497-g001){#F1}

Genotyping and Quality Control
------------------------------

Genotyping and quality control of the Pittsburgh 3DFN and Penn State cohorts were previously described by [@B8]. Briefly, for the Pittsburgh 3DFN cohort, DNA was extracted from saliva samples and genotyped along with 72 HapMap control samples on the Illumina HumanOmniExpress + Exome v1.2 array (Illumina, San Diego, CA, United States) plus custom content by the Center for Inherited Disease Research (CIDR). Samples were interrogated for genetic sex, chromosomal aberrations, relatedness, genotype call rate, and batch effects. SNPs were interrogated for call rate, discordance among 70 duplicate samples, Mendelian errors among HapMap controls (parent-offspring trios), deviations from Hardy-Weinberg equilibrium, and sex differences in allele frequencies and heterozygosity. To assess population structure, we performed a PCA within each cohort using subsets of uncorrelated SNPs. Based on the scatterplots of the PCs and scree plots of the eigenvalues, we determined that population structure was captured in four PCs of ancestry for the 3DFN cohort. Imputation of unobserved variants was performed using haplotypes from the 1000 Genomes Project Phase 3 as the reference. Imputation was performed using IMPUTE2 ([@B25]). We used an info score of \>0.5 at the SNP level and a genotype probability of \>0.9 at the SNP-per-participant level as filters for imputed SNPs. Masked variant analysis, in which genotyped SNPs were imputed in order to assess imputation quality, indicated high accuracy of imputation.

Participants in the Penn State cohort were genotyped using the Illumina Human Hp200c1 BeadChip; and the 23andMe v3 and v4 arrays. Samples were interrogated for genetic sex, chromosomal aberrations, relatedness, genotype call rate, and batch effects. SNPs were evaluated for call rate, discordant genotype calls between duplicate samples, Mendelian errors in HapMap control parent--offspring trios, deviation from Hardy--Weinberg genotype proportions and sex differences in allele frequency and heterozygosity. Imputation was performed as described for the 3DFN cohort. An ADMIXTURE analysis was done with the 1000 Genomes Phase 1 dataset as the reference, to select subjects with European ancestry ([@B3]).

Participants from the ALSPAC cohort were genotyped using the Illumina HumanHap550 quad genome-wide SNP genotyping platform, by Sample Logistics and Genotyping Facilities at the Wellcome Trust Sanger Institute (Cambridge, United Kingdom) and the Laboratory Corporation of America (Burlington, NC, United States), supported by 23andMe. Haplotypes were estimated using SHAPEIT2 ([@B12]) and imputed to the 1000 genomes reference panel (Phase 1, Version 3) ([@B1]) using IMPUTE2 ([@B25], [@B24]).

The following procedure was used to identify and exclude biological relatives in the ALSPAC cohort. First, SNPs with a minor allele frequency (MAF) less than 5% or more than 5% genotype data missing, were filtered out. Second, SNPs were pruned for linkage disequilibrium (LD) with r^2^ set at 0.2 in a pairwise manner, with a moving window size of 50 variants shifting five variants each step. Finally, related individuals were identified and removed when the proportion of identity by descent (IBD) was higher than 0.125. To control for population structure, self-identified non-European individuals were removed, and then genetic outliers (*n* = 15) were removed based on z-scores calculated in the first 10 PCs. Z-scores higher than six indicated outliers, who were subsequently removed after which PCA was computed again. These calculations were done using PLINK 1.9 ([@B43]). After these steps, ancestry axes were determined with PCA and used as described above.

Candidate Genes
---------------

SNPs reported to influence testosterone levels in the human body were identified from the literature. Since free circulating testosterone levels are variable and not easy to measure, proxy-measurements have been used to estimate the levels of free testosterone in the human body. Dehydroepiandrosterone (DHEAS) is the most prevalent circulating steroid in humans ([@B50]) and is a precursor for testosterone. Furthermore, SHBG binds to free circulating testosterone and estradiol and is therefore a good proxy for testosterone levels in the body. Therefore, genetic studies of testosterone regulation have focused on free circulating testosterone, DHEAS, and/or SHBG. Forty-three testosterone-related SNPs were selected based on genetic association results from seven publications ([@B40]; [@B55]; [@B11]; [@B27]; [@B42]; [@B7]; [@B46]; Supplementary Table [S1](#SMT1){ref-type="supplementary-material"}). 32 of these SNPs were present in all three cohorts and were tested for association with the 63 facial modules. Three SNPs were not tested because of MAF \< 5% in one or more cohorts and the other SNPs were excluded due to low imputation quality in one or more cohorts.

Statistical Testing and Meta-Analysis
-------------------------------------

Canonical correlation analysis (CCA) was used to test the effect of 32 SNPs on facial shape using the multivariate phenotypes derived as described above. CCA is a multivariate testing framework which extracts the linear combination of PCs from a facial module that has maximal correlation with the SNP being tested. The correlation was tested for significance by a Roa's *F*-test approximation (right tail, one-sided test), after removing the effects of age, age^2^, sex, weight, height, facial size and the first four dimensions of ancestry using PLSR. Both the independent (SNP) as the dependent (facial shape) variables were corrected for these covariates.

Since the direction of the effect through the face shape space determined by the CCA can and will differ across the three cohorts, we use a two-step procedure where CCA is performed in one cohort, after which the two other cohorts were projected onto the direction of the effect found in CCA. Thus, three meta-analyses were performed in a round-robin fashion with each of the three cohorts serving as the discovery set for the CCA and the other two serving as replication sets. Association tests were performed in the replication sets by projecting the PCs onto the loadings calculated in the discovery CCA, which returned a specific genetic effect score. As described in [@B8], the phenotypic trait discovered in CCA, can be explicitly measured in the replication datasets. The genetic effect score was subsequently used in a standard linear regression with the SNPs as independent variables. This function employs a t-statistic and a positive-sided *p*-value was obtained with the Student's T cumulative distribution function ([@B13]). The *p*-values were combined according to Stouffer's method (1949). The facial segments are overlapping and hierarchically constructed (thus not completely independent). Therefore we determined 37 independent segments by the Li and Ji method ([@B34]). Thirty-two candidate SNPs were tested, of which 30 were independent. An additional correction factor was added due to the three meta-analyses performed. Therefore, the Bonferroni-corrected significance *p*-value cut-off was *p* \< 1.50E-05 (i.e., 0.05/(37×30×3)).

Analyses were repeated for males (*n* = 4055) and females (*n* = 2892) separately, and in a strictly post-pubertal cohort (age \> 15 years; *n* = 6947).

Investigating Alternative Phenotypes: Facial Ratios
---------------------------------------------------

Several standard facial ratios have been previously associated with either testosterone levels or testosterone-related phenotypes (e.g., aggression, perceived masculinity) ([@B6]; [@B20]; [@B18]; [@B23]). We therefore looked at the relationship between our candidate SNPs and five facial ratio measurements in the Pittsburgh 3DFN cohort (*n* = 2297), including standard facial width-to-height ratios (Supplementary Figure [S1](#SMF1){ref-type="supplementary-material"}). These ratios were calculated based on linear distance measurements collected directly on the 3D facial images or through direct anthropometry (see [@B53] for details).

A total of 42 of the 43 literature-identified SNPs associated to testosterone levels were available for testing in the Pittsburgh 3DFN cohort (genotyping and quality control of this cohort is described above). All five ratios were adjusted by sex, age and body size before genetic analysis, then linear models were used to test genetic association between each phenotype and each SNP adjusting for the first four PCs of ancestry using PLINK. The Bonferroni-corrected significance *p*-value cut-off was *p* \< 0.00119 (i.e., 0.05/42). For completeness, associations in subgroups of the total study population were also investigated: males only (*n* = 856), females only (*n* = 1323), and post-pubertal (\>14 years) participants (*n* = 1750).

Results
=======

Association of Testosterone-Associated SNPs With Facial Shape Modules
---------------------------------------------------------------------

We tested 32 SNPs for genetic association with 63 multivariate facial modules. Two of the 32 tested SNPs showed significant associations with modules in the mandible region in at least one of the three meta-analyses: rs12150660 (*p* = 1.07E-07) and rs1799941 (*p* = 6.15E-06) (Table [1](#T1){ref-type="table"} and Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). Both of these SNPs are located in introns of the *SHBG* gene, and have been shown to affect circulating SHBG as previously described in literature ([@B40]; [@B27]). SHBG is a binding globulin secreted by the liver and its major function is to bind and transport circulating sex hormones with a high affinity; transporting them into the circulation and regulating their action by controlling their bioavailability ([@B11]; [@B50]). In the circulation, 50--60% of the free testosterone is bound to SHBG, while only 1--2% is free-circulating ([@B27]). Low levels of circulating SHBG are associated with decreased glucose control and are predictors for type 2 diabetes ([@B32]). Subjects with the minor allele of rs12150660 were more likely to show lower testosterone levels ([@B40]), while subjects with the minor allele of rs1977741 showed higher testosterone levels ([@B27]). The minor alleles of both SNPs were associated with a broader and more protruding mandible -- a characteristic feature associated with male faces. While the effects of rs1799941 were localized to the mandibular region, rs12150660 showed additional effects in modules containing the philtrum and was associated specifically with midfacial retrusion or a more protruded chin (Figures [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}). Since both identified SNPs are in LD (*r*^2^ = 0.89), it is possible that only one of them is actually functional, or both of them may be in strong LD with yet another untested causal variant ([@B40]). This could mean that, although being in high LD, both SNPs might still have a separate effect on SHBG and testosterone levels in the body, reflected in the face. The same phenotypic effect of these SNPs was observed in the post-pubertal subset (Supplementary Figure [S2](#SMF2){ref-type="supplementary-material"}). No significant associations were observed in the male- and female-only subsets. Meta-analysis results for all 32 SNPs are displayed in Supplementary Table [S2](#SMT2){ref-type="supplementary-material"}.

###### 

Discovery and meta-analysis results of rs12150660 and rs1799941 for the 3D facial modules.

  SNP          Location (hg19)   Candidate gene   Allele   MAF      Module   CCA     Meta-analysis   
  ------------ ----------------- ---------------- -------- -------- -------- ------- --------------- ----------
  rs12150660   17:7618597        SHBG             G \> T   0.0925   6        0.163   2.02E-02        1.07E-07
                                                                             0.178   1.67E-01        7.08E-06
                                                                             0.154   7.65E-05        5.03E-05
  rs1799941    17:7630105        SHBG             G \> A   0.10     12       0.145   1.70E-02        6.15E-06
                                                                             0.129   6.87E-01        9.80E-04
                                                                             0.137   3.41E-04        2.08E-03

For the allele column, major allele \> minor allele. MAF = minor allele frequency (based on 1000 genomes phase 3 for Europeans). Genome build hg19 is used as standard reference genome sequence to indicate the genomic location of the variants. The module number refers to Figure

1

and shows the facial segment with the lowest p-value for the SNP. CCA shows the canonical correlation (CC) analysis results for the module listed. Results are ordered by row according to which cohort served as discovery in the meta-analysis: Pittsburgh, Penn State, ALSPAC. The meta-analysis p-values are ordered in the same manner. The first p-value (under CCA) represents the statistical significance observed for the cohort separately. The second p-value (under meta-analysis) represents with combined statistical significance observed with each cohort serving in the discovery position.

![Meta-analysis results for rs12150660. **(A)** Representation of the significant modules of the meta-analysis based on the different discovery datasets. **(B)** Heat map displacement plot of the effect of rs12150660 on facial morphology, with red representing an outward displacement and blue representing an inward displacement. **(C)** Surface warp showing the effect (exaggerated) of the major allele (G) on lower facial shape. **(D)** Surface warp showing the effect (exaggerated) of the minor allele (T) on lower facial shape.](fgene-09-00497-g002){#F2}

![Meta-analysis results of rs1799941. **(A)** Representation of the significant modules of the meta-analysis based on the different discovery datasets. **(B)** Heat map displacement plot of the effect of rs1799941 on facial morphology, with red representing an outward displacement and blue representing an inward displacement. **(C)** Surface warp showing the effect (exaggerated) of the major allele (G) on lower facial shape. **(D)** Surface warp showing the effect (exaggerated) of the minor allele (A) on lower facial shape.](fgene-09-00497-g003){#F3}

Testing Facial Ratios
---------------------

Based on the findings of Hodges-Simeon and others, who have showed an association between pubertal testosterone levels and ratios of facial width-to-height ([@B33]; [@B23]), we tested five facial ratios in our candidate gene approach. The genetic associations between the candidate SNPs and the ratios (Supplementary Table [S3](#SMT3){ref-type="supplementary-material"}) were investigated in the entire 3DFN sample, in males/females separately, and in a post-pubertal subpopulation. One of the 42 testosterone SNPs we tested (rs8023580) showed an association with two related facial ratios in the male-only subset: total facial width-to-height (*p* = 9.61E-04) and upper facial width-to-height (FWH1; *p* = 7.35E-04). rs8023580 is an intronic SNP in *NR2F2-AS1*, a non-coding RNA showing high expression in the ovary. The complete results are shown in Supplementary Table [S3](#SMT3){ref-type="supplementary-material"}. The nearby *NR2F2* gene has been implicated in testicular Leydig function, essential for male testosterone production ([@B26]). Furthermore, several animal studies suggest an influence of *NR2F2* on craniofacial morphology. *NR2F2* is expressed in the mandibular component of the first branchial arch in mice. In zebrafish, it has been reported that *NR2F* genes are required for upper jaw formation ([@B4]). Furthermore, loss of these genes transforms the maxillary component of the upper jaw into lower-jaw-like structures. [@B14] suggested that the expression of *NR2F2* might be regulated by *NR2F2-AS1* via *MAFB*, which is a gene known to be involved in craniofacial development ([@B14]). In a recent GWAS of human facial morphology, variants near *MAFB* were shown to be associated with overall width of the cranial base ([@B48]). This measure is a reasonable proxy for upper facial width, which is a key determinant of the facial width-to-height ratios associated with *NR2F2-AS1* variants here.

Discussion
==========

The impact of sex hormones on human craniofacial morphology is well documented and is most apparent in the post-pubertal dimorphism we see between male and female faces ([@B28]; [@B38]). The most prominent sex differences in human facial morphology tend to involve the mandible, zygomatic region (cheeks), lips, forehead, and nose ([@B49]; [@B31]; [@B28]; [@B38]). Prior studies have connected these aspects of facial morphology to both testosterone levels directly or to other physical and behavioral markers of testosterone activity ([@B51]; [@B54]; [@B23]). If this causal model is correct, then any factor affecting testosterone levels should also impact facial morphology along with a host of other sexually dimorphic traits. We now understand that the level of free testosterone in individuals is at least partly under genetic control ([@B40]; [@B55]; [@B11]; [@B27]; [@B42]; [@B7]; [@B46]). In the present study, we performed an *in silico* candidate gene study to investigate the effects of common genetic variants known to impact testosterone levels on normal-range facial morphology. The SNPs we chose were previously reported in several large-scale GWAS to influence free testosterone levels in adults. We observed associations with three of these SNPs in two genes: *SHBG* and *NR2F2-AS1*. These SNPs were shown to impact specific regions of the face that show strong evidence of sex differences -- the mandible, lips, and upper face. The lower third of the face (mandibular region), in particular, has been shown to correlate strongly with traits related to prenatal testosterone exposure, such as second-to-fourth digit ratio. In prior research, individuals with lower digit ratios (indicating greater prenatal testosterone exposure) showed broader, more robust, and more protrusive mandibles ([@B39]; [@B52]). In contrast, nasal morphology, which often shows striking differences post-puberty between males and females ([@B28]), was not associated with these or any other SNPs we tested.

The mechanism of effect of the implicated variants on facial morphology is still unclear. Testosterone affects a wide array of tissues and organs during development. Through altering testosterone levels, our implicated SNPs may impact the cell populations involved in facial growth and development. In this indirect model, testosterone acts as a mediator. However, testosterone levels are extremely variable during life, with a peak during puberty and a gradual decline thereafter ([@B19]). Also, there are immense intra-individual variation in testosterone levels, based on immune activation, caloric intake, interaction with other hormones, and several psychosocial variables ([@B19]). Therefore, the influence of testosterone levels on craniofacial growth is likely to be extremely complex. The testosterone-related genetic variants considered here were selected from GWAS studies on adults, while the vast majority of facial growth occurs prior to adulthood ([@B16]). Different sets of genetic variants may affect testosterone levels in adults and children. This could be one reason many of the SNPs we investigated did not show effects on facial morphology. Testing genetic variants associated with circulating testosterone levels in subadults, during the active craniofacial growth phase, may yield improved results. Another possibility is that we lacked power to detect facial effects for some of the variants we tested. Power to detect testosterone-mediated genetic associations with facial morphology, which depends on the allele frequency of the variant, the effect size of the SNP on testosterone, and the effect size of testosterone on the face, differ across the SNPs tested in this study. Therefore, failure to detect an association should not be interpreted to mean that there is no effect.

Interestingly, some variants, in addition to impacting free testosterone levels, may also have a direct effect on facial morphology. Supporting this idea is a recent experimental study implicating *NR2F* genes in craniofacial morphogenesis, and, in particular, jaw development ([@B4]). However, there is currently no evidence supporting a similar role for *SHBG* or showing expression of this gene in developing facial tissues. Additional experimental follow-up studies will be required to understand the mechanisms through which these variants influence facial traits.

Several GWAS of normal-range facial morphology have now been published ([@B35]; [@B41]; [@B2]; [@B48]; [@B8]). Because these studies utilize an unbiased approach taking into account variants spread across the entire genome, they provide rich datasets to explore the influence of specific genetic pathways (in this case the testosterone pathway) on craniofacial morphology in a hypothesis-driven manner. Accordingly, the results here provide additional insights into the genetic basis of human facial features that would likely be missed in a typical GWAS, due to the very stringent adjustments for statistical significance required to control type-1 error inflation. This more targeted approach can help us identify biologically relevant genetic variants with more subtle effects on craniofacial morphology. That being said, because we identified our candidate SNPs from the literature, we are likely only testing a small fraction of the variants associated with testosterone levels (the ones that these studies had the power to detect) and we do not know the functional status of most of these variants. All of the variants associated with facial morphology in our study were non-coding. In future studies, it may be fruitful to consider interactions between variants implicated in this study and additional variants in other pathways reported to influence the same facial traits.

Conclusion
==========

We reported three SNPs associated to testosterone levels in the body with a clear effect on mandible shape (rs12150660 and rs1799941) and facial width to height ratios (rs8023580), indicating that testosterone-related genetic variants affect normal-range facial morphology, and in particular, facial features known to exhibit strong sexual dimorphism in humans.
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Five facial ratios tested for association with the candidate SNPs. **(A)** Total facial width to height ratio (Total FWH). **(B)** Upper facial width to height ratio -- version 1 (Upper FWH1). **(C)** Upper facial width to height ratio -- version 2 (Upper FWH2). **(D)** Lower facial width to height ratio (Lower FWH). **(E)** Upper to lower facial width ratio (Upper:Lower FW).

###### 

Click here for additional data file.
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Results of the meta-analysis in the post-pubertal subset. Representation of the significant modules of the meta-analysis based on the different discovery datasets.
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List of 44 candidate SNPs selected from the literature.
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Complete meta-analysis results for all 32 SNPs tested on the 63 3D facial modules.
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Results for the 42 candidate SNPs tested for association with five facial ratios in the 3DFN cohort.
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